Evonik posts 40% rise in Q3 adjusted EBITDA and expects full-year result at top of guidance

EN
eFeedLink Newsdesk
4 Nov 2026
Evonik posts 40% rise in Q3 adjusted EBITDA and expects full-year result at top of guidance

Animal Nutrition sales rose on higher essential amino acid volumes and prices, helping Advanced Technologies lift adjusted EBITDA 87% in the third quarter.

Share:LinkedInX